chimeric antigen receptor t cell therapy

chimeric antigen receptor t cell therapy

Da: CAR-T
0 0 3 mesi fa
Notably, several CAR-T libraries have been generated not only for blood cancer antigen CD19, but also for solid tumors against different antigens, such as Her2, Her3, EGFR, FGFR1, VEGFR, etc. The selected stable clones can be used in clinic trials immediately, thus making this technology more powerful and attractive in chimeric antigen receptor t cell therapy. https://www.creative-biolabs.com/car-t/cellrapeutics-chimeric-antigen-receptor-car-technology.htm

Seguici su Facebook

Copyright 2019 - Spreaker Inc. a Voxnest Company - Crea un podcast - New York, NY
Aiuto